Clinical Trial Update: Study of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ZE94-0605 in patients with advanced solid tumors, including dose expansion cohorts. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor
• Solid Tumors

Drugs mentioned

• ZE94-0605

Snippet

Sponsor: Eilean Therapeutics | Conditions: Solid Tumor Malignancies, Solid Cancer | Phase 1 | Status: NOT_YET_RECRUITING